Engineering Peptides that Target Disordered Regions in PAX3-FOXO1–Positive Alveolar Rhabdomyosarcoma
Alveolar rhabdomyosarcoma is an aggressive childhood cancer, and many children with this disease carry a mutation that combines two different proteins, PAX3 and FOXO1, into one protein, PAX3-FOXO1. This creates a protein with new function, causing changes in gene expression that leads to cancer. Children with this mutation face poor outcomes. This fusion protein is highly dynamic and samples many different structures, too many to reasonably count in fact. This makes the protein hard to drug because we traditionally target stably folded regions of proteins.




